The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Ganesh Manoharan
Showing 1-8 of 8 articles
Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study
Manoharan G,
Grube E,
Van Mieghem N,
Brecker S,
Fiorina C,
Kornowski R,
Danenberg H,
Ruge H,
Thiele H,
Lancellotti P,
Søndergaard L,
Tamburino C,
Oh J,
Fan Y,
Windecker S
November 20, 2020 | 10.4244/EIJ-D-20-00279
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I,
Dumonteil N,
Blackman D,
Tchetché D,
Walters D,
Hildick-Smith D,
Manoharan G,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Feldman T,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program
Manoharan G,
Belardi J,
Du Z,
Lee M,
Qiao S,
Serruys P,
Windecker S,
Xu B,
Yeung A
January 20, 2017 | 10.4244/EIJ-D-16-00079
TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery
van Gils L,
Tchetché D,
Latib A,
Sgroi C,
Manoharan G,
Möllmann H,
Van Mieghem N
September 18, 2016 | 10.4244/EIJV12SYA6
Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system
Manoharan G,
Linke A,
Möllmann H,
Redwood S,
Frerker C,
Kovac J,
Walther T
August 20, 2016 | 10.4244/EIJV12I6A125
First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve
Jeger R,
Manoharan G,
Kaiser C
March 20, 2014 | 10.4244/EIJV9I11A229
St Jude Medical Portico valve
Manoharan G,
Spence M,
Rodés-Cabau J,
Webb J
September 30, 2012 | 10.4244/EIJV8SQA18
Complications of transcatheter aortic valve implantation: avoidance and management
Hildick-Smith D,
Redwood S,
Mullen M,
Thomas M,
Kovac J,
Brecker S,
Trivedi U,
Young C,
Hutchinson N,
MacCarthy P,
Prendergast B,
De Belder M,
Monaghan M,
Blackman D,
Baumbach A,
Manoharan G,
Moat N
September 30, 2011 | 10.4244/EIJV7I5A99
1
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke